Skye Bioscience Phase 2 Trial of Weight Loss Drug Nimacimab Misses Primary Endpoint; Shares Plunge Pre-Bell-February 2024-www.financetom.com

Skye Bioscience Phase 2 Trial of Weight Loss Drug Nimacimab Misses Primary Endpoint; Shares Plunge Pre-Bell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Skye Bioscience Phase 2 Trial of Weight Loss Drug Nimacimab Misses Primary Endpoint; Shares Plunge Pre-Bell

Oct 6, 2025 5:20 AM

07:47 AM EDT, 10/06/2025 (MT Newswires) -- Skye Bioscience ( SKYE ) shares plummeted more than 58% in recent premarket activity after it said Monday that its phase 2a trial of nimacimab to treat patients with obesity missed its primary endpoint of weight loss compared with placebo.

The company said its preliminary analysis found that the 200 mg, subcutaneous weekly dose "was suboptimal as a monotherapy."

Skye Bioscience ( SKYE ) said it will host a conference call and webcast to discuss the results at 8 am ET.

Price: 1.98, Change: -2.77, Percent Change: -58.32

Previous page： Pennymac Financial Services Insider Sold Shares Worth $4,669,165, According to a Recent SEC Filing Next page： NuScale Power Raises $227.7 Million From Warrant Exercise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pennymac Financial Services Insider Sold Shares Worth $4,669,165, According to a Recent SEC Filing

Dec 26, 2024

04:57 PM EST, 12/26/2024 (MT Newswires) -- Doug Jones, Director, Director, President & Chief Mortgage Banking Officer, on December 20, 2024, sold 45,947 shares in Pennymac Financial Services ( PFSI ) for $4,669,165. Following the Form 4 filing with the SEC, Jones has control over a total of 481,774 shares of the company, with 23,892 shares held directly and 457,882...

NuScale Power Raises $227.7 Million From Warrant Exercise

Dec 26, 2024

05:01 PM EST, 12/26/2024 (MT Newswires) -- NuScale Power ( SMR ) said late Thursday about 97% of its warrants were exercised by holders to buy its class A shares at $11.50 per share at redemption date, raising $227.7 million for the firm. The company said no warrants remained outstanding and they have ceased trading on the New York Stock...

NorthView Acquisition Gets Delisting Notification From Nasdaq

Dec 26, 2024

04:58 PM EST, 12/26/2024 (MT Newswires) -- NorthView Acquisition ( NVAC ) shares will be delisted from the Nasdaq after the company failed to comply with the exchange's rule of completing one or more business combinations within 36 months of the initial public offering, the company said Thursday. NorthView said that it received a notification from the exchange's listing qualifications...

Red Cat Holdings Insider Sold Shares Worth $5,737,057, According to a Recent SEC Filing

Dec 26, 2024

04:56 PM EST, 12/26/2024 (MT Newswires) -- Jeffrey M Thompson, 10% Owner, Director, Chairman of the Board, CEO, on December 20, 2024, sold 500,000 shares in Red Cat Holdings ( RCAT ) for $5,737,057. Following the Form 4 filing with the SEC, Thompson has control over a total of 13,014,449 shares of the company, with 13,014,449 shares held directly. SEC...